Barriers to the wider adoption of medicinal Cannabis.
The use of Cannabis-based preparations for medicinal use has waxed and waned in the multi-millennial history of human co-existence with the plant and its cultivation. Recorded use of preparations from Cannabis is effectively as old as recorded history with examples from China, India and Ancient Egypt. Prohibition and restriction of availability allowed a number of alternatives to take the place of Cannabis preparations. However, there has been a worldwide resurgence in medicinal Cannabis advocacy from the public. Media interest has been piqued by particular evocative cases. Altogether, therefore, there is pressure on healthcare professionals to prescribe and dispense Cannabis-based preparations. This review enunciates some of the barriers which are slowing the wider adoption of medicinal Cannabis.
Keywords: Cannabis; cannabidiol; cannabinoid; tetrahydrocannabinol.
© The British Pain Society 2020.
Conflict of interest statement
Conflict of interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
History of cannabis and its preparations in saga, science, and sobriquet.
Chem Biodivers. 2007 Aug;4(8):1614-48. doi: 10.1002/cbdv.200790144. Chem Biodivers. 2007. PMID: 17712811
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial.
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
Cannabis, cannabidiol, and epilepsy–from receptors to clinical response.
Epilepsy Behav. 2014 Dec;41:277-82. doi: 10.1016/j.yebeh.2014.08.135. Epub 2014 Oct 1. Epilepsy Behav. 2014. PMID: 25282526 Review.
Cannabis and epilepsy: An ancient treatment returns to the fore.
Epilepsy Behav. 2017 May;70(Pt B):292-297. doi: 10.1016/j.yebeh.2016.09.040. Epub 2016 Dec 15. Epilepsy Behav. 2017. PMID: 27989385 Review.
L’article Barriers to the wider adoption of medicinal Cannabis. est apparu en premier sur Cannabis Belgique.